Literature DB >> 25499642

Altering the response to radiation: sensitizers and protectors.

Deborah E Citrin1, James B Mitchell2.   

Abstract

A number of agents are used clinically to enhance the efficacy of radiotherapy today, many of which are cytotoxic chemotherapies. Agents that enhance radiation induced tumor cell killing or protect normal tissues from the deleterious effects of ionizing radiation are collectively termed radiation modifiers. A significant effort in radiobiological research is geared towards describing and testing radiation modifiers with the intent of enhancing the therapeutic effects of radiation while minimizing normal tissue toxicity. In this review, we discuss the characteristics of these agents, the testing required to translate these agents into clinical trials, and highlight some challenges in these efforts. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25499642      PMCID: PMC4270009          DOI: 10.1053/j.seminoncol.2014.09.013

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  60 in total

1.  The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation.

Authors:  M D Sklar
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

2.  A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector.

Authors:  Ryan M Davis; Anastasia L Sowers; William DeGraff; Marcelino Bernardo; Angela Thetford; Murali C Krishna; James B Mitchell
Journal:  Free Radic Biol Med       Date:  2011-05-25       Impact factor: 7.376

3.  Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions.

Authors:  Kevin Camphausen; Benjamin Purow; Mary Sproull; Tamalee Scott; Tomoko Ozawa; Dennis F Deen; Philip J Tofilon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

4.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

5.  Compartmental responses after thoracic irradiation of mice: strain differences.

Authors:  Chi-Shiun Chiang; Wei-Chung Liu; Shih-Ming Jung; Fang-Hsin Chen; Chi-Rong Wu; William H McBride; Chung-Chi Lee; Ji-Hong Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

6.  In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762.

Authors:  James B Mitchell; Rajani Choudhuri; Kristin Fabre; Anastasia L Sowers; Deborah Citrin; Sonya D Zabludoff; John A Cook
Journal:  Clin Cancer Res       Date:  2010-03-16       Impact factor: 12.531

Review 7.  DNA repair targeting and radiotherapy: a focus on the therapeutic ratio.

Authors:  John Thoms; Robert G Bristow
Journal:  Semin Radiat Oncol       Date:  2010-10       Impact factor: 5.934

8.  Fluoropyrimidine-Radiation Interactions in Cells and Tumors.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1997-10       Impact factor: 5.934

Review 9.  Targeting the metabolic microenvironment of tumors.

Authors:  Kate M Bailey; Jonathan W Wojtkowiak; Arig Ibrahim Hashim; Robert J Gillies
Journal:  Adv Pharmacol       Date:  2012

10.  Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Authors:  Padraig Warde; Malcolm Mason; Keyue Ding; Peter Kirkbride; Michael Brundage; Richard Cowan; Mary Gospodarowicz; Karen Sanders; Edmund Kostashuk; Greg Swanson; Jim Barber; Andrea Hiltz; Mahesh K B Parmar; Jinka Sathya; John Anderson; Charles Hayter; John Hetherington; Matthew R Sydes; Wendy Parulekar
Journal:  Lancet       Date:  2011-11-02       Impact factor: 79.321

View more
  11 in total

1.  Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice.

Authors:  Justin Cohen; Akbar Anvari; Santanu Samanta; Yannick Poirier; Sandrine Soman; Allen Alexander; Maida Ranjbar; Ramilda Pavlovic; Andrew Zodda; Isabel L Jackson; Javed Mahmood; Zeljko Vujaskovic; Amit Sawant
Journal:  Br J Radiol       Date:  2019-02-12       Impact factor: 3.039

2.  Short-Term Screening Assays for the Identification of Therapeutics for Cancer.

Authors:  Deborah E Citrin
Journal:  Cancer Res       Date:  2016-06-15       Impact factor: 12.701

3.  Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy.

Authors:  Shun Kishimoto; Jeffrey R Brender; Gadisetti V R Chandramouli; Yu Saida; Kazutoshi Yamamoto; James B Mitchell; Murali C Krishna
Journal:  Antioxid Redox Signal       Date:  2020-09-15       Impact factor: 7.468

Review 4.  The Advances in Epigenetics for Cancer Radiotherapy.

Authors:  Yuexuan Wang; Yu Han; Yuzhen Jin; Qiang He; Zhicheng Wang
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

5.  Selective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal models.

Authors:  D J Martinel Lamas; M B Nicoud; H A Sterle; E Carabajal; F Tesan; J C Perazzo; G A Cremaschi; E S Rivera; V A Medina
Journal:  Cell Death Discov       Date:  2015-12-21

6.  The Radiosensitization of Sodium Glycididazole on Nasopharyngeal Carcinoma Cells via Enhancing DNA Damage and Promoting Apoptosis.

Authors:  Xiaoli Min; Fangling Huang; Huichao Huang; Shuang Zhao; Guoqiang Wang; Minze Zhou; Zhuchu Chen; Maoyu Li; Yongheng Chen
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

Review 7.  Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways.

Authors:  Wei Meng; Joshua D Palmer; Michael Siedow; Saikh Jaharul Haque; Arnab Chakravarti
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

8.  Radiation-Induced Senescence Reprograms Secretory and Metabolic Pathways in Colon Cancer HCT-116 Cells.

Authors:  Chandrasekharam N Nagineni; Sarwat Naz; Rajani Choudhuri; Gadisetti V R Chandramouli; Murali C Krishna; Jeffrey R Brender; John A Cook; James B Mitchell
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 9.  The future of nanosized radiation enhancers.

Authors:  Agnes Pottier; Elsa Borghi; Laurent Levy
Journal:  Br J Radiol       Date:  2015-08-07       Impact factor: 3.039

10.  Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells.

Authors:  Hyejin Park; Ye Ji Jeong; Na-Kyung Han; Joong Sun Kim; Hae-June Lee
Journal:  Int J Mol Sci       Date:  2018-08-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.